China pharma holdings q3 loss per share $0.02

China pharma holdings, inc. reports third quarter 2019 financial results.q3 loss per share $0.02.q3 revenue rose 3.4 percent to $2.4 million.china pharma- faced negative effects on sales from implementation of government policy to control spending proportion on drugs to patients' expenses.china pharma- faced pressure from stringent requirements of drug registration standards, consistency evaluations.china pharma- will further evaluate market conditions for current existing products, pipeline products, and competition in the market.
CPHI Ratings Summary
CPHI Quant Ranking